The FDA has marked the ANDA084700 application for Chlordiazepoxide Hydrochloride as discontinued.
The product was an oral capsule containing 10 mg of Chlordiazepoxide Hydrochloride, identified by product number 001, and its marketing status is now discontinued.
The original ANDA (submission 1) received approval on July 2, 1976, and a supplemental manufacturing (CMC) submission (submission 11) was approved on January 3, 1983.
The sponsor of the application is Roxane.
Regulatorische Updates22. Sept. 2026•1 Min. Lesezeit
FDA Discontinues Chlordiazepoxide Hydrochloride ANDA084700
The FDA has listed the ANDA084700 application for Chlordiazepoxide Hydrochloride 10 mg oral capsules as discontinued. Sponsor Roxane filed the original ANDA in 1976.
Zusammengestellt vom PharmaCountry-Team · Quelle: FDA.gov
Bewertungen
(0)
(0)
(0)
(0)
(0)
Weitere Artikel
Alle Einblicke anzeigenStudien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026
Bewertung hinterlassen